15 completed, 3 unknown, 1 terminated, 1 withdrawn. 20 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 20 | Completed 15, Unknown 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 8 | Completed 6, Unknown 2 |
Follow Panic Disorder: new trials by email Literature Review of Panic Disorder trials Research Report on Panic Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study Cannabidiol (CBD) Oil Capsules, Sunflower Lecithin Oil in Capsule - Generalized Anxiety Disorder, Social Anxiety Disorder | Phase 3 | Unknown | McMaster University | 50 | 2021-12-15 | 2023-02-14 |
| Xenon Inhalation for Treatment of Panic Disorder Xenon, Placebo - Panic Disorder | Phase 2 / Phase 3 | Unknown | Nobilis Therapeutics Inc. | 200 | 2021-06-01 | 2021-03-03 |
| Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study 50:2 mg(CBD:THC)/ml - Cannabinoid Oil Oral Preparation- titrated as tolerated up to a maximum 8mls twice daily (200 mg- 800 mg total dose), Placebo Oil - Generalized Anxiety Disorder, Social Anxiety Disorder | Phase 3 | Withdrawn | McMaster University | 2021-04-01 | 2021-03-24 | |
| D-cycloserine Augmented CBT for Panic Disorder d-cycloserine, placebo, cognitive-behaviour therapy - Panic Disorder | Phase 3 | Terminated | University of Oxford | 33 | 2012-10-01 | 2018-05-03 |
| Online Treatments for Mood and Anxiety Disorders in Primary Care CCBT+ISG/Collaborative Care, CCBT/Collaborative Care - Depression, Generalized Anxiety Disorder | Phase 2 / Phase 3 | Completed | University of Pittsburgh | 700 | 2012-02-01 | 2020-08-05 |
| Mechanisms of Panic Disorders Treatment Cognitive Behavioural Therapy (CBT) - Panic Disorder, Agoraphobia | Phase 2 / Phase 3 | Unknown | University Medicine Greifswald | 180 | 2010-03-01 | 2011-04-11 |
| Treatment of Social Phobia and Panic Disorder in Adults individual cognitive-behavioural therapy, stepped care model - Social Phobia, Panic Disorder | Phase 3 | Completed | Haukeland University Hospital | 174 | 2008-03-01 | 2016-01-26 |
| Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse Personality-targeted interventions - Alcohol Abuse, Drug Abuse | Phase 2 / Phase 3 | Completed | King's College London | 3190 | 2007-05-01 | 2011-06-27 |
| Comparison of Psychotherapy Programs to Treat Panic Disorder Cognitive behavioral therapy, Applied relaxation training (ART), Panic focused psychodynamic psychotherapy (PFPP) - Anxiety Disorders, Panic Disorder | Phase 3 | Completed | Weill Medical College of Cornell University | 201 | 2006-09-01 | 2022-12-23 |
| Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks levetiracetam - Panic Disorder | Phase 3 | Completed | Lindner Center of HOPE | 15 | 2006-01-01 | 2011-12-13 |
| Study Comparing Venlafaxine vs. Paroxetine in Panic Disorder VENLAFAXINE, Paroxetine - Panic Disorders | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 70 | 2005-01-01 | 2010-04-02 |
| Internet-Versus Group-Administered Cognitive Behavior Therapy for Panic Disorder Internet-based cognitive behavior therapy (CBT)., Group CBT - Panic Disorder | Phase 3 | Completed | Karolinska Institutet | 113 | 2004-12-01 | 2009-02-18 |
| Telephone-Based Care Management Program for Individuals With Anxiety Disorders Telephone-based collaborative care, Usual care - Anxiety Disorders, Panic Disorder | Phase 3 | Completed | University of Pittsburgh | 360 | 2004-03-01 | 2014-01-22 |
| Personality-targeted Interventions for Adolescent Alcohol Misuse PRE-Venture: Personality Risk Education - Alcohol Abuse, Drug Abuse | Phase 2 / Phase 3 | Completed | King's College London | 710 | 2003-11-01 | 2011-06-27 |
| Study Evaluating Venlafaxine ER in Patients With Panic Disorder Venlafaxine ER - Panic Disorder | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 653 | 2001-11-01 | 2009-08-14 |
| Study Evaluating Venlafaxine ER in Adults With Panic Disorder Venlafaxine ER - Panic Disorder | Phase 3 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 343 | 2001-04-01 | 2009-08-14 |
| Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders Telephone-based collaborative care management - Panic Disorder, Anxiety Disorder | Phase 2 / Phase 3 | Completed | University of Pittsburgh | 2000-07-01 | 2014-01-22 | |
| Psychodynamic Therapy for Treating Panic Disorder PFPP, ART - Panic Disorder | Phase 2 / Phase 3 | Completed | Weill Medical College of Cornell University | 49 | 2000-02-01 | 2013-06-27 |
| Therapies for Treatment-Resistant Panic Disorder Symptoms Clonazepam, Sertraline, Cognitive behavioral therapy - Panic Disorder | Phase 2 / Phase 3 | Completed | Massachusetts General Hospital | 46 | 1999-03-01 | 2014-06-11 |
| Treatment of Panic Disorder: Long Term Strategies Cognitive behavior therapy, Paroxetine or other medication - algorithm used - Panic Disorder, Agoraphobia | Phase 3 | Completed | New York State Psychiatric Institute | 379 | 1999-02-01 | 2014-03-18 |
Anxiety Disorders (9) · Agoraphobia (5) · Generalized Anxiety Disorder (4) · Depression (3) · Phobia, Social (3) · Alcoholism (2) · Conduct Disorder (2) · Disease (2) · Marijuana Abuse (2) · Substance-Related Disorders (2) · Antisocial Personality Disorder (1) · Behavior, Addictive (1) · Binge Drinking (1) · Recurrence (1)
Mental Disorders (20) · Anxiety Disorders (11) · Phobic Disorders (6) · Chemically-Induced Disorders (4) · Behavior (3) · Behavioral Symptoms (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Alcohol-Related Disorders (2) · Attention Deficit and Disruptive Behavior Disorders (2) · Neurodevelopmental Disorders (2) · Substance-Related Disorders (2) · Alcohol Drinking (1) · Compulsive Behavior (1) · Disease Attributes (1)
Cognitive Behavioral Therapy (5) · Paroxetine (2) · Behavior Therapy (1) · Cannabidiol (1) · Capsules (1) · Clonazepam (1) · Cycloserine (1) · Exercise (1) · Levetiracetam (1) · Oils (1) · Psychotherapy, Psychodynamic (1) · Sertraline (1) · Venlafaxine Hydrochloride (1) · Xenon (1)
University of Pittsburgh (3) · Wyeth is now a wholly owned subsidiary of Pfizer (3) · King's College London (2) · McMaster University (2) · Weill Medical College of Cornell University (2) · Haukeland University Hospital (1) · Karolinska Institutet (1) · Lindner Center of HOPE (1) · Massachusetts General Hospital (1) · New York State Psychiatric Institute (1) · Nobilis Therapeutics Inc. (1) · University Medicine Greifswald (1) · University of Oxford (1)
United States (8) · United Kingdom (3) · Canada (2) · Brazil (1) · Germany (1) · Norway (1) · Sweden (1)
Bruce L. Rollman, MD, MPH (2) · Michael Van Ameringen, MD, FRCPC (2) · Alexander L. Gerlach, Prof. Dr. (1) · Alfons O. Hamm, Prof. Dr. (1) · Andrea Reinecke, PhD (1) · Barbara Milrod, M.D. (1) · Barbara Milrod, MD (1) · Bruce L. Rollman, MD (1) · Catherine Harmer, PhD (1) · David H Barlow, PhD (1) · Georg W. Alpers, Prof. Dr. (1) · Jack Gorman, MD (1) · Jacques P. Barber, PhD (1) · Katherine H. Shear, MD (1)
PMID 18373143, PMID 20732631, PMID 16330721, PMID 17592913, PMID 19026262, PMID 19358784, PMID 19814948, PMID 20048226, PMID 20598127, PMID 20869813, PMID 21110842, PMID 21977355, PMID 23344135, PMID 26011508, PMID 26081010, PMID 26663632, PMID 26708332, PMID 26877119, PMID 26881449, PMID 27235836, PMID 27464313, PMID 29336228, PMID 30256548, PMID 30341278, PMID 30718541, PMID 30773148, PMID 30821630, PMID 30865304, PMID 30869969, PMID 31712720, PMID 31734525, PMID 31838872, PMID 32105128, PMID 32229324, PMID 32584211, PMID 32734299, PMID 32880104, PMID 34267085, PMID 38231552
R01MH059395 (2), K23MH001831 (1), K23MH001849 (1), R01MH045963 (1), R01MH045964 (1), R01MH045965 (1), R01MH045966 (1), R01MH070664 (1)